全球神經調控設備市場規模、佔有率、趨勢及成長分析報告（2026-2034年）

預計神經調節設備市場將從 2025 年的 64.5 億美元成長到 2034 年的 139.8 億美元，2026 年至 2034 年的複合年成長率為 8.97%。

隨著醫療機構採用先進技術治療神經系統疾病，神經調控設備的市場也不斷成長。這些設備，例如脊髓刺激設備、深部腦部刺激器和迷走神經刺激設備，可為慢性疼痛、運動障礙、癲癇和憂鬱症疾病提供治療性介入。神經系統疾病盛行率的不斷上升以及人們對微創、標靶治療日益成長的關注，正在推動這些設備在臨床和居家醫療環境中的應用。

技術創新正在提高治療的精準度和患者療效。封閉回路型系統、植入式刺激器和無線連接技術實現了即時監測和自適應治療調整。人工智慧驅動的演算法最佳化刺激參數，實現個人化治療，而電池和材料的創新則增強了設備的耐用性和生物相容性。遠端監測平台使臨床醫生能夠追蹤治療進度並調整治療方案，無需頻繁往返醫院。

預計未來成長將主要由慢性疼痛、精神疾病和復健等領域的廣泛應用所推動。北美和歐洲憑藉其先進的醫療基礎設施處於主導地位，而隨著神經系統疾病診療服務的擴展，亞太地區的應用也不斷推進。設備製造商、研究機構和臨床中心之間的策略合作正在加速創新。結合以患者為中心的設計和最尖端科技的神經調控設備有望成為精準神經治療的關鍵工具。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球神經調控設備市場：依產品分類

• 市場分析、洞察與預測
• 脊髓刺激設備
• 深部腦部刺激器
• 薦骨神經刺激器
• 迷走神經刺激設備
• 胃電刺激
• 其他

第5章 全球神經調控設備市場：依應用領域分類

• 市場分析、洞察與預測
• 帕金森氏症
• 慢性疼痛
• 癲癇
• 偏頭痛
• 尿失禁和糞便失禁
• 震顫
• 憂鬱症
• 其他

第6章 全球神經調控設備市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院和門診手術中心（ASC）
• 診所和物理治療中心
• 其他

第7章 全球神經調控設備市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott Laboratories
  • Medtronic Plc
  • Boston Scientific Corporation
  • Nexstim Plc
  • LivaNova Plc
  • Neuropace Inc
  • Nevro Corporation
  • ElectroCore Inc
  • Axonics Inc
  • Laborie Inc

The Neuromodulation Devices Market size is expected to reach USD 13.98 Billion in 2034 from USD 6.45 Billion (2025) growing at a CAGR of 8.97% during 2026-2034.

The neuromodulation devices market is growing as healthcare providers adopt advanced technologies for neurological disorder management. These devices, including spinal cord stimulators, deep brain stimulators, and vagus nerve stimulators, offer therapeutic interventions for chronic pain, movement disorders, epilepsy, and depression. Increasing prevalence of neurological diseases and emphasis on minimally invasive, targeted therapies are driving adoption across clinical and homecare settings.

Technological innovation is advancing treatment precision and patient outcomes. Closed-loop systems, implantable stimulators, and wireless connectivity allow real-time monitoring and adaptive therapy adjustments. AI-driven algorithms optimize stimulation parameters for personalized treatment, while battery and material innovations enhance device longevity and biocompatibility. Remote monitoring platforms enable clinicians to track progress and adjust therapy without frequent hospital visits.

Future growth is expected from expanding applications in chronic pain, psychiatric disorders, and rehabilitation. North America and Europe lead due to advanced healthcare infrastructure, while Asia-Pacific adoption is rising with expanding neurological care services. Strategic partnerships between device manufacturers, research institutions, and clinical centers are accelerating innovation. Neuromodulation devices are positioned to become essential tools in precision neurotherapeutics, combining patient-centric design with cutting-edge technology.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Spinal Cord Stimulators
• Deep Brain Stimulators
• Sacral Nerve Stimulators
• Vagus Nerve Stimulators
• Gastric Electrical Stimulation
• Others

By Application

• Parkinson's Disease
• Chronic Pain
• Epilepsy
• Migraine
• Urinary & Faecal Incontinence
• Tremor
• Depression
• Others

By End-use

• Hospitals & Ambulatory Surgery Centers (ASC)
• Clinics & Physiotherapy Centers
• Others

COMPANIES PROFILED

• Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Nexstim plc, LivaNova plc, Neuropace Inc, Nevro Corporation, electroCore Inc, Axonics Inc, Laborie Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEUROMODULATION DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Spinal Cord Stimulators Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Deep Brain Stimulators Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Sacral Nerve Stimulators Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Vagus Nerve Stimulators Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Gastric Electrical Stimulation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEUROMODULATION DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Parkinson's Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Chronic Pain Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Epilepsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Migraine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Urinary & Faecal Incontinence Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Tremor Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Depression Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEUROMODULATION DEVICES MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals & Ambulatory Surgery Centers (ASC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinics & Physiotherapy Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NEUROMODULATION DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL NEUROMODULATION DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott Laboratories
  • 9.2.2 Medtronic Plc
  • 9.2.3 Boston Scientific Corporation
  • 9.2.4 Nexstim Plc
  • 9.2.5 LivaNova Plc
  • 9.2.6 Neuropace Inc
  • 9.2.7 Nevro Corporation
  • 9.2.8 ElectroCore Inc
  • 9.2.9 Axonics Inc
  • 9.2.10 Laborie Inc